Zacks Investment Research on MSN
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch of Countable 10, the first and only PCR ...
Move positions company at the heart of Cambridge’s innovation ecosystem to accelerate growth and collaboration in infection prevention. CAMBRIDGE, MA / ACCESS Newswire / October 14, 2025 / Next Gen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback